Monday, November 18, 2024
- 9:00AM-10:30AM
-
Abstract Number: 2528
Activation of the Hes1/Piezo1 Pathway Promotes Mechanical Stress Response and Prevents Glucocorticoid-induced Osteoporosis
Plenary III- 9:00AM-10:30AM
-
Abstract Number: 2531
CRISPR Deletion Screen in Fibroblasts Identifies Novel Regulators of Inflammation
Plenary III- 9:00AM-10:30AM
-
Abstract Number: 2527
Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primary Sjogren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (DAHLIAS)
Plenary III- 9:00AM-10:30AM
-
Abstract Number: 2529
Improving Outcomes and Narrowing Disparities in Juvenile Idiopathic Arthritis (JIA): A Division-Wide, Equity-Focused Quality Improvement Project
Plenary III- 9:00AM-10:30AM
-
Abstract Number: 2532
Mortality in Patients with Pre-existing Autoimmune Disease on Immune Checkpoint Inhibitor Therapy
Plenary III- 9:00AM-10:30AM
-
Abstract Number: 2530
Single-cell Multi-omics Analysis of Reactive Lymph Nodes, Affected Tissues, and Blood Reveals a Naive-like CD4+TRAIL+ T Cell Population That Differentially Directs Effector Anti-nuclear Antigen Reactive Responses in Patients with Sjogren’s Syndrome and Systemic Sclerosis
Plenary III- 10:30AM-12:30PM
-
Abstract Number: 1855
Identification of Autoreactive Cytotoxic T Cells in ANCA-Associated Vasculitis
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 10:30AM-12:30PM
-
Abstract Number: 2363
“How Quickly Will I Feel Better with This New Drug?” – Rapidity of Treatment Response in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Analysis from Two Phase 3 Studies
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2154
“I Have Taken Five Different Kinds of Tablets and Injections, and I Still Have Foot Pain”: An International Outcome Measures in Rheumatology (OMERACT) Qualitative Study Exploring Patient Perspectives of Foot and Ankle Disorders
Patient Outcomes, Preferences, & Attitudes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1882
30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 1959
A 3-arm, Randomized, Open-label, Parallel Active Controlled, Multicentre International Study to Compare the Response of Ultrasound-assessed Synovitis to Baricitinib, Alone and Combined with Methotrexate versus Etanercept in Rheumatoid Arthritis Patients
Imaging of Rheumatic Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 2031
A Contemporary Assessment of the Burden of Malignancy in IgG4-Related Disease
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2243
A Cross-sectional Study of the Association Between Anxiety State and Various Factors in Patients with Rheumatoid Arthritis